|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Plaque Psoriasis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Psoriasis | |||||
| 3 | More general conditions related to this trial | ||||
| Skin Diseases | |||||
| Skin Diseases, Papulosquamous | |||||
| 4 | Interventions listed in this trial | ||||
| PH-10 (rose bengal disodium 0.001%) | |||||
| Control | |||||
| 5 | Sponsors listed in this trial | ||||
| Provectus Pharmaceuticals | |||||